bacillus Calmette-Guerin


Also found in: Dictionary, Encyclopedia.
Related to bacillus Calmette-Guerin: Bacillus Calmette-Guerin vaccine, Bacillus Calmette-Guérin

bacillus Cal·mette-Gué·rin

(kăl-mĕt′gā-răn′, käl-mĕt′gā-răN′)
n. Abbr. BCG
An attenuated strain of tubercle bacillus grown in repeated cultures on medium containing bile and used in tuberculosis vaccines. Also called bacille Calmette-Guérin.
References in periodicals archive ?
Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Bacillus Calmette-Guerin Therapy Doses (Induction and Maintenance)
Bacillus Calmette-Guerin lymphadenitis: A 6-year experience in two Saudi hospitals.
Bacillus Calmette-Guerin was started to be administered on days 15-20 following resection.
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
Bruce, "Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors," The Journal of Urology, vol.
A false-positive test may happen if you have been vaccinated recently with the bacillus Calmette-Guerin (BCG) vaccine.
TEHRAN (FNA)- Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guerin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas.
Intravesical Bacillus Calmette-Guerin (BCG) is an attenuated nonpathogenic strain of Mycobacterium bovis that was initially used as a vaccine against tuberculosis.
The baby was given Bacillus Calmette-Guerin (BCG) vaccination immediately after delivery as routine procedure.
Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis commonly used in the management of high-risk non-muscle-invasive bladder cancer [1].

Full browser ?